UNICYCIVE THERAPEUTICS, INC. Conversion of Stock, Shares Issued
UNICYCIVE THERAPEUTICS, INC. (UNCY) reported Conversion of Stock, Shares Issued of 18.42 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesIssued1 · last filed 2026-03-30
- UNICYCIVE THERAPEUTICS, INC. conversion of stock, shares issued for the quarter ending 2025-12-31 was 0.00 shares.
- UNICYCIVE THERAPEUTICS, INC. conversion of stock, shares issued for the quarter ending 2025-09-30 was -184.19K shares.
- UNICYCIVE THERAPEUTICS, INC. conversion of stock, shares issued for the quarter ending 2025-06-30 was 18.42K shares.
- UNICYCIVE THERAPEUTICS, INC. conversion of stock, shares issued for the quarter ending 2025-03-31 was 184.19K shares, a 0.00% change year-over-year.
- UNICYCIVE THERAPEUTICS, INC. conversion of stock, shares issued for fiscal 2025 was 18.42K shares, a 90.00% decline from fiscal 2024.
- UNICYCIVE THERAPEUTICS, INC. conversion of stock, shares issued for fiscal 2024 was 184.19K shares, a 0.00% change from fiscal 2023.
- UNICYCIVE THERAPEUTICS, INC. conversion of stock, shares issued for fiscal 2023 was 184.19K shares, a 0.00% change from fiscal 2022.
- UNICYCIVE THERAPEUTICS, INC. conversion of stock, shares issued for fiscal 2022 was 184.19K shares, a 0.00% change from fiscal 2021.
| Period end | Conversion of Stock, Shares Issued 3 month | Conversion of Stock, Shares Issued 6 month | Conversion of Stock, Shares Issued 9 month | Conversion of Stock, Shares Issued 12 month |
|---|---|---|---|---|
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -184.19K shares derived: sum of 2 quarters · filed 2026-03-30 | -165.77K shares derived: sum of 3 quarters · filed 2026-03-30 | 18.42K shares 10-K · filed 2026-03-30 |
| 2025-09-30 | -184.19K shares derived: 10-K 12 month − 3 quarters · filed 2026-03-30 | -165.77K shares derived: sum of 2 quarters · filed 2026-03-30 | 18.42K shares 10-Q · filed 2025-11-12 | 18.42K shares derived: sum of 4 quarters · filed 2026-03-30 |
| 2025-06-30 | 18.42K shares 10-Q · filed 2025-08-14 | 202.61K shares derived: sum of 2 quarters · filed 2025-08-14 | 202.61K shares derived: sum of 3 quarters · filed 2025-08-14 | 202.61K shares derived: sum of 4 quarters · filed 2025-08-14 |
| 2025-03-31 | 184.19K shares 10-Q · filed 2025-05-14 | 184.19K shares derived: sum of 2 quarters · filed 2025-05-14 | 184.19K shares derived: sum of 3 quarters · filed 2025-05-14 | 184.19K shares derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 0.00 shares derived: sum of 2 quarters · filed 2025-03-31 | 0.00 shares derived: sum of 3 quarters · filed 2025-03-31 | 184.19K shares 10-K · filed 2025-03-31 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 0.00 shares derived: sum of 2 quarters · filed 2024-11-13 | 184.19K shares 10-Q · filed 2024-11-13 | 184.19K shares derived: sum of 4 quarters · filed 2024-11-13 |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | 184.19K shares 10-Q · filed 2024-08-14 | 184.19K shares derived: sum of 3 quarters · filed 2024-08-14 | 184.19K shares derived: sum of 4 quarters · filed 2024-08-14 |
| 2024-03-31 | 184.19K shares 10-Q · filed 2024-05-13 | 184.19K shares derived: sum of 2 quarters · filed 2024-05-13 | 184.19K shares derived: sum of 3 quarters · filed 2024-05-13 | 184.19K shares derived: sum of 4 quarters · filed 2024-05-13 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 0.00 shares derived: sum of 2 quarters · filed 2024-03-28 | 0.00 shares derived: sum of 3 quarters · filed 2024-03-28 | 184.19K shares 10-K · filed 2024-03-28 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2023-11-14 | 184.19K shares 10-Q · filed 2023-11-14 | 184.19K shares derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 184.19K shares 10-Q · filed 2023-08-14 | 184.19K shares derived: sum of 3 quarters · filed 2023-08-14 | 184.19K shares derived: sum of 4 quarters · filed 2023-08-14 |
| 2023-03-31 | 184.19K shares 10-Q · filed 2023-05-16 | 184.19K shares derived: sum of 2 quarters · filed 2023-05-16 | 184.19K shares derived: sum of 3 quarters · filed 2023-05-16 | 184.19K shares derived: sum of 4 quarters · filed 2023-05-16 |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | 0.00 shares derived: sum of 2 quarters · filed 2023-03-31 | 0.00 shares derived: sum of 3 quarters · filed 2023-03-31 | 184.19K shares 10-K · filed 2023-03-31 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2022-11-14 | 184.19K shares 10-Q · filed 2022-11-14 | 184.19K shares derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | 184.19K shares 10-Q · filed 2022-08-15 | 184.19K shares derived: sum of 3 quarters · filed 2022-08-15 | |
| 2022-03-31 | 184.19K shares 10-Q · filed 2022-05-12 | 184.19K shares derived: sum of 2 quarters · filed 2022-05-12 | ||
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | 184.19K shares 10-K · filed 2022-03-31 | ||
| 2021-09-30 | 184.19K shares 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |